Stocks
Arcturus Therapeutics Holdings (ARCT) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -740.6% | -1 632% | 6.66% | -44.2% | -15.3% | -40.0% | ||
| Changes by years, y/y, % | -623pp | -891pp | +1 638pp | -51pp | +29pp | -35.1% | |||
Arcturus Therapeutics Holdings. EBITDA margin, %
Arcturus Therapeutics Holdings. EBITDA margin, changes, pp
Arcturus Therapeutics Holdings (ARCT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -44.5% | -26.6% | -78.4% | -35.8% | -23.6% | -40.0% | |
| Changes by years, y/y, % | -123pp | -105pp | -55pp | +501pp | +10pp | |||
| Changes by quarters, q/q, % | -11pp | +18pp | -52pp | +43pp | +12pp | |||
